TABLE 8.
Multivariate analysis for 5-year mortality after HTX.
| Parameter | Hazard Ratio | 95% CI | P-value |
| Recipient age (years) | 1.018 | 0.996 – 1.041 | 0.103 |
| Recipient body mass index (kg/m2) | 1.012 | 0.969 – 1.058 | 0.592 |
| Recipient arterial hypertension (in total) | 0.704 | 0.404 – 1.228 | 0.217 |
| Recipient dyslipidemia (in total) | 0.935 | 0.548 – 1.596 | 0.805 |
| Recipient T2DM (in total) | 1.563 | 1.053 – 2.319 | 0.027 * |
| Previous CABG surgery (in total) | 0.783 | 0.434 – 1.412 | 0.415 |
| Ischemic CMP (in total) | 1.718 | 0.993 – 2.972 | 0.053 |
| Cardiac amyloidosis (in total) | 1.697 | 0.985 – 2.923 | 0.057 |
CABG, coronary artery bypass graft; CI, confidence interval; CMP, cardiomyopathy; HTX, heart transplantation; T2DM, type 2 diabetes mellitus; *, statistically significant (P < 0.050).